PL2739266T3 - Trwałe przeciwzapalne roztwory do wstrzyknięcia - Google Patents

Trwałe przeciwzapalne roztwory do wstrzyknięcia

Info

Publication number
PL2739266T3
PL2739266T3 PL12819309T PL12819309T PL2739266T3 PL 2739266 T3 PL2739266 T3 PL 2739266T3 PL 12819309 T PL12819309 T PL 12819309T PL 12819309 T PL12819309 T PL 12819309T PL 2739266 T3 PL2739266 T3 PL 2739266T3
Authority
PL
Poland
Prior art keywords
injection
stable anti
inflammatory
inflammatory solutions
solutions
Prior art date
Application number
PL12819309T
Other languages
English (en)
Inventor
Gregory A. Demopulos
Wayne R. Gombotz
Hui-Rong Shen
Original Assignee
Omeros Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47627326&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2739266(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Omeros Corporation filed Critical Omeros Corporation
Publication of PL2739266T3 publication Critical patent/PL2739266T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
PL12819309T 2011-08-04 2012-08-03 Trwałe przeciwzapalne roztwory do wstrzyknięcia PL2739266T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161515234P 2011-08-04 2011-08-04
EP12819309.1A EP2739266B1 (en) 2011-08-04 2012-08-03 Stable anti-inflammatory solutions for injection

Publications (1)

Publication Number Publication Date
PL2739266T3 true PL2739266T3 (pl) 2017-07-31

Family

ID=47627326

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12819309T PL2739266T3 (pl) 2011-08-04 2012-08-03 Trwałe przeciwzapalne roztwory do wstrzyknięcia

Country Status (21)

Country Link
US (3) US20130035362A1 (pl)
EP (1) EP2739266B1 (pl)
JP (2) JP6174579B2 (pl)
KR (1) KR101951064B1 (pl)
CN (1) CN103957886B (pl)
AR (1) AR089203A1 (pl)
AU (1) AU2012289968B2 (pl)
BR (1) BR112014002631B1 (pl)
CA (1) CA2844152C (pl)
CL (1) CL2014000267A1 (pl)
DK (1) DK2739266T3 (pl)
ES (1) ES2600153T3 (pl)
HK (1) HK1198911A1 (pl)
IL (1) IL230779B (pl)
MX (1) MX347373B (pl)
NZ (1) NZ621484A (pl)
PL (1) PL2739266T3 (pl)
PT (1) PT2739266T (pl)
RU (1) RU2635521C2 (pl)
WO (1) WO2013020021A1 (pl)
ZA (1) ZA201401344B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201707528WA (en) 2013-03-15 2017-10-30 Tonix Pharmaceuticals Inc Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
US10646574B2 (en) * 2014-07-21 2020-05-12 Board Of Regents, The University Of Texas System Formulations of intraarticular pharmaceutical agents and methods for preparing and using the same
TWI809304B (zh) 2014-12-01 2023-07-21 奥默羅斯公司 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液
US20170049134A1 (en) * 2015-08-18 2017-02-23 Empire Technology Development Llc Meat tendering using food grade natural products for reducing muscle contraction
JP7023690B2 (ja) 2017-12-06 2022-02-22 株式会社東芝 道路維持管理システム、道路維持管理方法及びコンピュータプログラム
WO2020188457A1 (en) * 2019-03-15 2020-09-24 Ftf Pharma Private Limited Solutions for oral dosage
JP7008887B2 (ja) 2019-11-01 2022-01-25 三菱電機株式会社 劣化状態判定装置、劣化状態検査システム、及び、劣化状態検査方法
FR3123563A1 (fr) * 2021-06-03 2022-12-09 Algotherapeutix Utilisation de l’amitriptyline et/ou l’un de ses sels pharmaceutiquement acceptable comme agent conservateur
CN116165306B (zh) * 2023-04-25 2023-11-17 湖南九典制药股份有限公司 酮洛芬凝胶贴膏中有关物质的分析测定方法及应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5624893A (en) * 1993-10-14 1997-04-29 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation
IT1269583B (it) * 1994-04-26 1997-04-08 Bayer Italia Spa Preparazioni farmaceutiche a base di una soluzione di ketoprofene in capsule di gelatina molle e metodo per la loro produzione
KR100517210B1 (ko) * 1994-12-12 2006-06-07 오메로스 코포레이션 통증,염증및경련억제용관주용액
CA2206119C (en) * 1994-12-12 2008-05-13 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain, inflammation and spasm
US7091181B2 (en) * 1994-12-12 2006-08-15 Omeros Corporation Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors
IT1277741B1 (it) * 1995-12-28 1997-11-12 Dompe Spa Composizioni farmaceutiche parenterali contenenti sali di alchilammonio di acidi 2-arilpropionici
US7973068B2 (en) * 1998-10-20 2011-07-05 Omeros Corporation Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
US7022740B2 (en) * 2004-04-29 2006-04-04 Leonard Mackles Lubricious ophthalmic solutions
US20070053868A1 (en) * 2005-03-08 2007-03-08 Banner Pharmacaps, Inc. Solvent system for enhancing the solubility of pharmaceutical agents
AU2006249684A1 (en) * 2005-05-20 2006-11-30 Omeros Corporation Cyclooxygenase inhibitor and calcium channel antagonist compositions and methods for use in urological procedures
AU2007223560A1 (en) * 2006-03-01 2007-09-13 Tristrata, Inc. Composition and method for topical treatment of tar-responsive dermatological disorders
EP2117513A2 (en) * 2007-02-05 2009-11-18 Carbylan Biosurgery, Inc. Polymer formulations for delivery of bioactive agents
WO2008115572A1 (en) * 2007-03-21 2008-09-25 Theraquest Biosciences, Inc. Methods and compositions of nsaids
WO2012112566A1 (en) * 2011-02-15 2012-08-23 Allergan, Inc. Pharmaceutical cream compositions of oxymetazoline for treating symptoms of rosacea

Also Published As

Publication number Publication date
HK1198911A1 (zh) 2015-06-19
CL2014000267A1 (es) 2014-08-29
CA2844152C (en) 2020-04-14
JP2017014288A (ja) 2017-01-19
MX347373B (es) 2017-04-25
CN103957886A (zh) 2014-07-30
IL230779A0 (en) 2014-03-31
EP2739266A1 (en) 2014-06-11
AU2012289968B2 (en) 2014-01-16
AU2012289968A1 (en) 2013-03-28
JP2014521694A (ja) 2014-08-28
PT2739266T (pt) 2016-10-04
CN103957886B (zh) 2016-03-30
ES2600153T3 (es) 2017-02-07
US20180344855A1 (en) 2018-12-06
US20160166696A1 (en) 2016-06-16
BR112014002631B1 (pt) 2022-04-19
JP6174579B2 (ja) 2017-08-02
RU2014108159A (ru) 2015-09-10
KR20140057579A (ko) 2014-05-13
US20130035362A1 (en) 2013-02-07
CA2844152A1 (en) 2013-02-07
NZ621484A (en) 2016-05-27
RU2635521C2 (ru) 2017-11-13
EP2739266A4 (en) 2014-12-31
ZA201401344B (en) 2016-10-26
IL230779B (en) 2019-05-30
KR101951064B1 (ko) 2019-02-21
DK2739266T3 (en) 2016-10-03
AR089203A1 (es) 2014-08-06
MX2014001368A (es) 2014-06-11
WO2013020021A1 (en) 2013-02-07
EP2739266B1 (en) 2016-07-27
BR112014002631A2 (pt) 2017-03-07

Similar Documents

Publication Publication Date Title
EP2667915A4 (en) INJECTOR
HK1188155A1 (en) Injection device
IL230000B (en) injection device
GB2488578B (en) Injection device
IL230001B (en) injection device
EP2750738A4 (en) INJECTION DEVICE
EP2788048A4 (en) INJECTION DEVICE
ZA201305720B (en) Stable bio-oil
AU343318S (en) Medicine injector
GB2490721B (en) Injection devices
GB2489730B (en) Injection device
HK1198911A1 (zh) 注射用的穩定消炎溶液
EP2709696A4 (en) INJECTION DEVICE
EP2717946A4 (en) INJECTION DEVICE
EP2690280A4 (en) INJECTION DEVICE
PL2574596T3 (pl) Zawór dozujący
GB201208320D0 (en) Injector
EP2699671A4 (en) INFLAMMATORY ACTIVE SUBSTANCES
HK1200704A1 (en) Anti-inflammatory compounds
PT2574597E (pt) Válvula de distribuição
EP2695613A4 (en) PAINKILLER
GB201100481D0 (en) Nozzle
HK1193407A1 (en) Pyrrolidine-3-ylacetic acid derivative -3-
EP2708238A4 (en) CYTOLYTIC CELL INDUCTION AGENT
GB2491707B (en) Fuel dispenser